HomeAyurveda ProductsPopular Categoryhimalaya liv. 52 ds tablet
thumbnail
thumbnail
thumbnail
Himalaya Liv. 52 DS Tablet

Himalaya Liv. 52 DS Tablet

Combo packs for this product

Pack of 2
combo
MRP
260
Buy Pack
Pack of 4
combo
MRP
520
Buy Pack

Combo packs for this product

combo
Pack of 2
Buy Pack
combo
Pack of 4
Buy Pack
MRP
130
of60 tablets
ADD TO CART
Additional offers
additional_offer_flag
Amazon Pay: 10% Cashback up to ₹125 | Valid once per user for Amazon Prime customers | Validity: 1 to 31 Mar
additional_offer_flag
Freecharge: 15% Cashback up to ₹50 | Valid once per user from 18 Sep to 31 Mar
additional_offer_flag
Mobikwik: 15% SuperCash up to ₹150 | Valid twice per user from 1 to 31 Mar

Information about Himalaya Liv. 52 DS Tablet

Himalaya Liv.52 DS is a double strength Hepatospecific formulation that contains Caper Bush (Himsra) and Chicory (Kasani) herbs. The Caper Bush contains p-methoxy benzoic acid for increasing the functional efficiency of the liver. Chicory is effective in protecting liver from alcohol toxicity. Liv 52 DS tablet is a daily health supplement that protect the hepatic parenchyma and stimulate hepatocellular regeneration to increase efficiency of the liver.
 
Two tablet of Liv 52 DS can be consumed twice or thrice a day after meals. 
 
Liv.52 DS Tablet improves digestion and assimilation process, promotes appetite. It reduces damage caused to liver due to Elevated liver enzyme, jaundice, and Hepatitis A & B.
 
Use under medical supervision.
One of the following licensed pharmacy from the nearest location will deliver Himalaya Liv. 52 DS Tablet. Once the pharmacy accepts your order, the details of the pharmacy will be shared with you. Acceptance of your order is based on the validity of your prescription and the availability of this medicine.
Frequently bought together
Himalaya Liv. 52 DS Tablet130
plus
Himalaya Confido Tablet120

TOTAL PRICE250
ADD BOTH TO CART
  • icon
    Authentic Products
  • icon
    Great Savings
  • icon
    Home Delivery
Content Details
Last updated on:
15 Mar 2019 | 07:25 PM (IST)
Want to know more?
Read Our Editorial Policy